Tiffany joined the BHL in May 2021 as a Master’s student in Pharmaceutical Sciences to work on the role of NOX2 as a new drug target in Alzheimer’s disease to repair blood-brain barrier dysfunction. Tiffany successfully defended and will graduate with a dual PharmD/MS degree on May 3. Congratulations, Tiffany!
Manekya presented at the 56th PGSRM
Manekya gave an oral presentation at the 56th Pharmaceutics Graduate Student Research Meeting (PGSRM) in Kansas City, MO, where she presented her project on Blood-Brain Barrier Dysfunction in Epilepsy.


